1. Home
  2. DV vs TRVI Comparison

DV vs TRVI Comparison

Compare DV & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DoubleVerify Holdings Inc.

DV

DoubleVerify Holdings Inc.

HOLD

Current Price

$10.83

Market Cap

1.6B

Sector

Technology

ML Signal

HOLD

Logo Trevi Therapeutics Inc.

TRVI

Trevi Therapeutics Inc.

HOLD

Current Price

$14.53

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DV
TRVI
Founded
2008
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.4B
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
DV
TRVI
Price
$10.83
$14.53
Analyst Decision
Buy
Strong Buy
Analyst Count
15
11
Target Price
$16.37
$21.55
AVG Volume (30 Days)
1.8M
1.7M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
31.91
EPS
0.04
N/A
Revenue
$748,291,000.00
N/A
Revenue This Year
$12.68
N/A
Revenue Next Year
$9.75
N/A
P/E Ratio
$272.13
N/A
Revenue Growth
13.92
N/A
52 Week Low
$7.61
$5.38
52 Week High
$16.82
$16.12

Technical Indicators

Market Signals
Indicator
DV
TRVI
Relative Strength Index (RSI) 53.99 60.16
Support Level $10.71 $10.07
Resistance Level $11.41 $16.12
Average True Range (ATR) 0.41 0.79
MACD -0.01 -0.08
Stochastic Oscillator 51.62 62.24

Price Performance

Historical Comparison
DV
TRVI

About DV DoubleVerify Holdings Inc.

DoubleVerify Holdings Inc is a media effectiveness platform that leverages artificial intelligence (AI) to drive superior outcomes for international brands by creating transparent ad transactions. Its solutions provide unbiased data analytics to improve the effectiveness, quality and return on advertising investments. DV Authentic Ad is its proprietary metric measuring whether an ad was delivered in a brand suitable environment, fully viewable, by a real person and in geography, while DV Pinnacle delivers these metrics in real time. The Company's solutions are integrated across programmatic platforms, social media channels and digital publishers, and are accredited by the Media Rating Council for digital ad measurement. It operates in the United States and international markets.

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.

Share on Social Networks: